Conference Coverage

Reports from professional meetings related to rhabdomyosarcoma.
Second Malignant Neoplasms (SMN) In Children Treated For Rhabdomyosarcoma: A Report From The Intergroup Rhabdomyosarcoma Studies (IRS) I-IV
Presenter: Sheri L. Spunt Affiliation: Children's Oncology Group Soft Tissue Sarcoma Committee, Arcadia, CA Background: Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma of the childhood (5%). Multimodality therapy ..
Presentation, Prognostic Factors and Patterns of Failure in Adult Rhabdomyosarcoma
Presenter: J.H. Simon Presenter's Affiliation: University of Iowa, Iowa City Type of Session: Scientific Background Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood, with about 400 new cases ..
Survival of Adult Rhabdomyosarcoma Patients Treated on Multimodality Protocols
Abstract Number: 339 Presenting Author: Naamit Gerber, MD Affiliation: Memorial Sloan Kettering Cancer Center, New York, NY Background Rhabdomyosarcoma (RMS) is a pediatric sarcoma rarely occurring in adults. Greater than ..
Results From the IRS IV Randomized Trial of Hyperfractionated Radiation in Children with Rhabdomyosarcoma
Presenter: S. S. Donaldson, MD Affiliation: The Intergroup Rhabdomyosarcoma Study Background: Hyperfractionated radiation therapy (HFRT) has the theoretical potential for improving efficacy without producing more late effects of children with ..
Dactinomycin (A) and vincristine (V) with or without cyclophosphamide (C) and radiation therapy (RT) for newly diagnosed patients with low-risk embryonal/botryoid rhabdomyosarcoma (RMS). An IRS-V report from the Soft Tissue Sarcoma Committee of the Childr
Presenter: Walterhouse JL et al.Presenter's Affiliation: Children's Hospital of Los Angeles, Los Angeles, CAType of Session: ScientificBackground The IRS-III and –IV studies defined 3 risk groups of rhabdomyosarcoma patients: low-risk ..

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More

OncoLink Cancer Treatment and Resources